SCHEMBL25355448

SCHEMBL25355448

CCn1nc(CC(=O)OC)c(=O)c2ccc(C(C)(C)F)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.38
▸ HPGD P15428 5/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ MAPT P10636 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ S1PR2 O95136 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ SLC22A12 Q96S37 2/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ CCR2 P41597 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25429842 0.84 RECQL (0.50) RECQLHPGDALDH1A1MAPTSMN1; SMN2
SCHEMBL25358251 0.81 MAPT (0.46) ALDH1A1MAPTSLC22A12KDM4ETSHR
SCHEMBL25356856 0.77 RECQL (0.37) RECQLHPGDALDH1A1MAPTSMN1; SMN2
SCHEMBL23909083 0.69 KDM4E (0.51) RECQLHPGDALDH1A1MAPTS1PR2
SCHEMBL23914662 0.69 DGAT1 (0.36) ALDH1A1MAPTKDM4ELMNAGLA
SCHEMBL23915446 0.69 SMN1; SMN2 (0.56) RECQLHPGDALDH1A1MAPTS1PR2
SCHEMBL29494684 0.69 MAPT (0.50) MAPTSLC22A12KMT2AMEN1
SCHEMBL23914648 0.68 MAPK8 (0.36) HPGDALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL25358880 0.68 ADORA2A (0.32) ESR1
SCHEMBL29492205 0.68 NLRP3 (0.43) RECQLALDH1A1SMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217346-B1 NEW COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2025-07-02 — — EP disclosed
US-20230391756-A1 NEW COMPOUND JANSSEN PHARMACEUTICA NV (BE) 2023-12-07 — — US disclosed
EP-4217346-A1 NEW COMPOUNDS JANSSEN Pharmaceutica NV (BE) 2023-08-02 — — EP disclosed
WO-2022063876-A1 NEW COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391756-A1 NEW COMPOUND NLRP3, NLRP1, IL1R1 RECQL 970/4885HPGD 1073/4885ALDH1A1 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback